TriviumVet launch The REVERSE CKD Study recruiting cats with Chronic Kidney Disease (CKD)
We at TriviumVet received great excitement at this year's Feline Veterinary Medicine Association (formerly AAFP) conference on the work we have been doing in the area of CKD. We are thrilled to announce that the long-awaited REVERSE CKD Study is now live and recruiting cats in veterinary care centres across the United States!
The REVERSE Study is a double blinded, randomised, placebo-controlled pivotal trial to test the effectiveness of TRIV307 in the management of the progression of Chronic Kidney Disease. The study is seeking cats diagnosed with CKD IRIS Stage II and Stage III to participate for a 9-month treatment period. All study costs are provided to the owner free of charge.
For more information on The REVERSE Study, including current study sites, enrolment criteria, or to register your cat or a patient, visit www.ckdincats.com